Promising new steroid drug could offer safer arthritis treatment
Early research has found that a new steroid drug, used for treating Duchenne Muscular dystrophy, has shown significant promise in treating inflammatory diseases such as rheumatoid arthritis.
Resea…
BHP announces exciting new role for its outgoing Chair
Birmingham Health Partners (BHP) has announced its Chair, Jonathan Pearson, will be stepping down at the end of his two-year term in September 2025, following his appointment as Chair of BHP member H…
Largest ever UK surgical trial aims to reduce post-surgery infections
More than £10m of funding from the National Institute for Health and Care Research (NIHR) has been awarded to BHP founder-member the University of Birmingham to run an ambitious trial which aims to r…
Birmingham teenager first in UK to receive groundbreaking diabetes treatment
A young patient identified by the ELSA study as having early stages of Type 1 Diabetes, has received treatment to delay the condition.
Sam, aged 14 and from Kings Norton, was the first to receive…
New UK network to strengthen regulatory environment for advanced therapies
A new network has been established to foster collaboration among regulators, industry, and researchers to ensure there is a world-leading regulatory environment in the UK for advanced therapies that…
Karen Crowdy and Linda Everard named first BHP People award winners
The BHP People award is a new reward and recognition scheme from Birmingham Health Partners, designed to shine a spotlight on our colleagues who play a vital role in the success of clinical trials an…